Moreover, the administration of butyrate has been shown to improve metabolic disorders, including hepatic lipogenesis and hyperglycemia through glucose transporter type 4, GLP-1, and AMP-activated protein kinase [48,49]. Here, GLP1R is linked to metabolic disease.